We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

184 hedge funds and large institutions have $1.11B invested in Viking Therapeutics in 2023 Q1 according to their latest regulatory filings, with 75 funds opening new positions, 48 increasing their positions, 46 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more funds holding in top 10

Funds holding in top 10: 1 → 4 (+3)

295% more first-time investments, than exits

New positions opened: 75 | Existing positions closed: 19

255% more capital invested

Capital invested by funds: $312M → $1.11B (+$795M)

228% more call options, than puts

Call options by funds: $83.9M | Put options by funds: $25.5M

43% more funds holding

Funds holding: 129 → 184 (+55)

40.25% more ownership

Funds ownership: 44.5% → 84.75% (+40%)

4% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 46

Holders
184
Holders Change
+55
Holders Change %
+42.64%
% of All Funds
2.93%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.06%
New
75
Increased
48
Reduced
46
Closed
19
Calls
$83.9M
Puts
$25.5M
Net Calls
+$58.3M
Net Calls Change
+$40.8M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$113M
2
State Street
State Street
Massachusetts
+$52M
3
Viking Global Investors
Viking Global Investors
Connecticut
+$20.2M
4
WA
Wasatch Advisors
Utah
+$17.6M
5
DM
Deerfield Management
New York
+$11.6M

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
-$5.88M
2
DTC
Deep Track Capital
Connecticut
-$5.73M
3
Millennium Management
Millennium Management
New York
-$5.62M
4
OCA
Octagon Capital Advisors
New York
-$5.12M
5
ECM
Endurant Capital Management
California
-$3.88M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACH
126
ArrowMark Colorado Holdings
Colorado
$265K – – –
BFM
127
Boothbay Fund Management
New York
$258K -$380K -36,813 -70%
FI
128
Financial Insights
Washington
$250K +$10.3K +1,000 +7%
CH
129
CVI Holdings
Delaware
$250K +$155K +15,000 New
WS
130
Wedbush Securities
California
$240K -$4.13K -400 -3%
MF
131
Magnetar Financial
Illinois
$237K +$147K +14,250 New
EGM
132
Engineers Gate Manager
New York
$234K +$145K +14,034 New
1WA
133
180 Wealth Advisors
Washington
$233K -$65.1K -6,300 -31%
ACP
134
Acuta Capital Partners
California
$233K +$145K +14,000 New
TAM
135
Titleist Asset Management
Texas
$233K +$145K +14,000 New
PFO
136
Pathstone Family Office
New Jersey
$232K +$144K +13,915 New
AllianceBernstein
137
AllianceBernstein
Tennessee
$227K +$141K +13,656 New
MFA
138
Mayflower Financial Advisors
Massachusetts
$225K – – –
SS
139
Simplicity Solutions
Minnesota
$223K +$138K +13,400 New
BHCM
140
Boulder Hill Capital Management
New York
$218K +$135K +13,100 New
TRCT
141
Tower Research Capital (TRC)
New York
$216K +$97K +9,391 +262%
N
142
Nuveen
North Carolina
$216K +$134K +12,948 New
CPA
143
Court Place Advisors
Maryland
$213K -$1.11M -107,520 -89%
JFG
144
Jefferies Financial Group
New York
$212K +$132K +12,751 New
IFWM
145
Institute for Wealth Management
Colorado
$204K – – –
FFM
146
Forum Financial Management
Illinois
$201K – – –
Man Group
147
Man Group
United Kingdom
$195K -$154K -14,953 Closed
LFAS
148
Level Four Advisory Services
Texas
$193K +$120K +11,600 New
PAMS
149
Pictet Asset Management (Switzerland)
Switzerland
$189K +$117K +11,369 New
SPIA
150
Steward Partners Investment Advisory
New York
$175K – – –
4 5
6
7 8

VKTX Hedge Fund Activity: Q1 2023 in Review

184 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q1 2023, worth a combined $1.11B — up 255% from $312M a quarter earlier.

Buyers outnumbered sellers: 75 funds opened new VKTX positions and 19 closed out — a net gain of 56 holders — while 48 added to existing stakes and 46 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $113M. The largest seller was Two Sigma Investments, cutting an estimated $5.88M.

  • 184 institutional investors held Viking Therapeutics (VKTX) as of Q1 2023, up from 129 in Q4 2022.
  • Funds reported $1.11B of Viking Therapeutics stock for Q1 2023, up 255% quarter-over-quarter.
  • 75 funds opened new Viking Therapeutics positions in Q1 2023 and 19 closed out, a net change of +56 holders.
  • The largest Viking Therapeutics buyer in Q1 2023 was Fidelity Investments, an estimated $113M added.
  • The largest Viking Therapeutics seller in Q1 2023 was Two Sigma Investments, an estimated $5.88M sold.

Based on aggregated 13F filings for Q1 2023.